Congress of psychiatry

relevance of ICF
Michael Linden, Germany
003
  Aims and indications for psychotherapy with 
bipolar disorders – past, present and future
Jan Scott, United Kingdom
004
  The aims and indications for psychotherapy 
with patients with treatment resistant depression: 
past, present and future
Michael Thase, USA
S-069 Symposium
13:30 – 15:00
 | 
Room  M4 / M5
TOPIC 3:
 Psychotic disorders
Virtual reality treatments for psychosis – the  
beginning of a new era?
Chairs: 
Wim Veling, The Netherlands 
Steffen Moritz, Germany
001
  Effect of virtual reality based CBT on cognitive 
biases in pychosis: a randomized clinical trial
Chris Geraets, The Netherlands
002
  Using virtual reality to reduce cognitive biases 
in psychosis
Mona Dietrichkeit, Germany
Matthias Nagel, Kristina Flint, Eva Krieger, Karsten 
Grzella, Steffen Moritz
003
  The effects of an Audio Visual Assisted Therapy 
Aid for Refractory auditory hallucinations (AVATAR 
therapy): a randomized controlled trial
Mar Rus-Calafell, United Kingdom
004
  Improving social cognition in people with a  
psychotic disorder: preliminary results of a pilot 
study on Dynamic interactive Social Cognition  
training in Virtual Reality (DiSCoVR)
Saskia Nijman, The Netherlands
S-070 Symposium
13:30 – 15:00
 | 
Room M1
TOPIC 25:
 Training and continuing education
Psychiatry across borders: international collabora-
tion between early career and trainee psychiatrists
Chairs: 
Ekin Sönmez, Turkey 
Olivier Andlauer, United Kingdom
001
  European Federation of Psychiatric Trainees 
(EFPT): 25 years of international collaboration
Howard Ryland, United Kingdom
002
  EPA ECPC – ongoing activities and future  
perspectives
Katja Koelkebeck, Germany
003
  WPA ECPs Section: aims and achievements
Hussien Elkholy, Egypt
004
  How an early career psychiatrists association 
can contribute to the beginning of professional life?
Mariana Paim Santos, Brazil
S-071 Symposium
13:30 – 15:00
 | 
Room Weimar 5
TOPIC 1:
 Neurocognitive disorders, organic mental 
disorders, dementia
Targeting subjective cognitive decline as an early 
indicator of dementia of the Alzheimer's type –  
current challenges and developments
Chairs: 
Tobias Luck, Germany 
Frank Jessen, Germany
001
  Going early: the challenges of harmonizing 
research on early and preclinical AD across borders
Frank Jessen, Germany
002
  Subtle neuropsychological impairments in 
subjective cognitive decline
Steffen Wolfsgruber, Germany
Michael Wagner

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
105
SCIENTIFIC
 PROGRAMME
003
  Dementia risk and patterns of self-reports of 
subjective cognitive decline
Susanne Roehr, Germany
Arno Villringer, Matthias C. Angermeyer, Tobias Luck, 
Steffi G. Riedel-Heller
004
  Cholinergic basal forebrain volume and connec-
tivity in subjective memory complainers and people 
with MCI
Stefan Teipel, Germany
Michel Grothe, Harald Hampel
S-072 Symposium
13:30 – 15:00
 | 
Room M6
TOPIC 10:
 Gerontopsychiatry
Geriatric psychiatry in Germany
›
 DGPPN Section: Geriatric Psychiatry
Chairs: 
Tillmann Supprian, Germany 
Hans Gutzmann, Germany
001
  Service provision for dementia patients in  
Germany – diagnostics and treatment
Michael Rapp, Germany
002
  Collaborative care in the treatment of late life 
depression
Michael Hüll, Germany
003
  Cognitive behavioural therapy in late-life  
depression
Georg Adler, Germany
004
  Delirium management and delirium prevention 
as a mission for the multi-professional psychogeri-
atric consultation-liaison-team
Christine Thomas, Germany
S-073 Symposium
13:30 – 15:00
 | 
Room Lindau 3
TOPIC 26:
 Ethics and philosophy
What happens if we solve our world's crisis with 
amygdala driven reactions?
›
 WPA Section: Conflict Management & Resolution
›
 WPA Section: Religion, Spirituality and Psychiatry
Chairs: 
Michael Sadre-Chirazi-Stark, Germany 
Peter J. Verhagen, The Netherlands
001
  What happens if we solve our world's crisis 
with amygdala driven reactions – social psychiatry 
perspectives
Roy Abraham Kallivayalil, India
002
  How does the juridical system respond to 
world's crisis – a diagnosis
Sabine Koenig, Germany
003
  Religion and conflict – what can we learn from 
comparative religion?
Peter J. Verhagen, The Netherlands
004
  Amygdala anxieties post Apartheid in South 
Africa: analysis of stressors and fears generating 
social instability
Solomon Tshimong Rataemane, South Africa
S-074 Symposium
13:30 – 15:00
 | 
Room Lindau 6
TOPIC 17:
 Psychotherapy
Cultural adaptation of cognitive behavioural therapy 
in different parts of the world
Chairs: 
Roger Ng, Hong Kong 
Shanaya Rathod, United Kingdom
001
  Overview of cultural adaptations of CBT
Shanaya Rathod, United Kingdom
002
  CBT in Chinese population: is there a need for 
adaptation?
Roger Ng, Hong Kong
003
  From Sufism to culturally adapted CBT:  
a journey to psychological healing
Muhammad Irfan, Pakistan
S-075 Symposium
13:30 – 15:00
 | 
Room Dessau 3
TOPIC 37:
 Stigma and mental health
Evidence for reducing stigma and discrimination in 
low and middle-income countries
›
 WPA Section: Epidemiology & Public Health
›
 WPA Section: Stigma and Mental Illness
Chairs: 
Graham Thornicroft, United Kingdom 
Prabha S. Chandra, India
001
  Introduction to the work of ‘Cities for Mental 
Health’
Chris Underhill, United Kingdom
002
  Mobilising youth for mental health
Moitreyee Sinha, USA
003
  Evaluating the impact of the “Cities for Mental 
Health” programme
Graham Thornicroft, United Kingdom

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
106
SCIENTIFIC
 PROGRAMME
S-076 Symposium
13:30 – 15:00
 | 
Room Dessau 6
TOPIC 3:
 Psychotic disorders
Understanding sleep disorders and their treatment 
in psychosis
Chairs: 
Felicity Waite, United Kingdom 
Daniel Freeman, United Kingdom
001
  Reduced sleep and psychotic experiences: an 
experimental study with mediation analysis
Sarah Reeve, United Kingdom
002
  Treating sleep problems in patients with  
distressing psychotic experiences
Felicity Waite, United Kingdom
003
  Stabilising sleep for patients admitted at acute 
crisis to a psychiatric hospital
Bryony Sheaves, United Kingdom
S-077 Symposium
13:30 – 15:00
 | 
Room R3
TOPIC 16:
 Diagnostics and classification, 
psychopathology, RDoC
What is machine learning and why will it change 
psychiatric research and practice?
Chairs: 
Dominic Dwyer, Germany 
Danilo Bzdok, Germany
001
  10 reasons why precision psychiatry will not be 
based on null-hypothesis testing
Danilo Bzdok, Germany
002
  From domain-knowledge to automatic feature 
engineering – recent advances in machine learning 
technology in psychiatry
Tim Hahn, Germany
003
  Applications and practical challenges of  
machine learning approaches in clinical psychiatry
Joseph Kambeitz, Germany
004
  Using functional MRI and machine learning in 
the categorization of genetic risk for different types 
of psychoses
Henrik Walter, Germany
S-078 Symposium
13:30 – 15:00
 | 
Room R13
TOPIC 22:
 Community and social psychiatry
Current issues in Nordic and Baltic psychiatry:  
challenges and possibilities
›
 ZONE 7: Northern Europe
Chairs: 
Jyrki Korkeila, Finland 
Sami Pirkola, Finland
001
  Evaluation of Mental Plan 2009, Finland
Sami Pirkola, Finland
002
  Do ethical codes differ according to region? 
Nordic approaches
Marianne C. Kastrup, Denmark
003
  Medicating ADHD in Iceland – hot topic in 
Iceland
Thorgunnur Arselsdottir, Iceland
004
  Current issues in Estonian psychiatry
Andres Lehtmets, Estonia
S-378 Symposium
13:30 – 15:00
 | 
Hall Helsinki 1
 
TOPIC 14:
 Neurobiology and genetics
Myelin plasticity and oligodendrocyte dysfunction 
in neuropsychiatric diseases
Chairs: 
Peter Falkai, Germany 
Klaus-Armin Nave, Germany
001
  Plasticity of myelin structure to adjust conduc-
tion velocity
Richard Doug Fields, USA
002
  Oligodendrocytes maintaining long range  
connectivity and axonal energy metabolism
Klaus-Armin Nave, Germany
003
  Neuronal activity regulating myelination in the 
adult brain
Michelle Monje, USA
004
  Catatonia – starting to understand mechanisms 
involving myelin
Hannelore Ehrenreich, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
107
SCIENTIFIC
 PROGRAMME
S-019 (d) 
Symposium (German)
13:30 – 15:00
 | 
Hall A1
 
TOPIC 35:
 Psychiatry and society
 
Zur Identität des Faches Psychiatrie und Psycho-
therapie
Chairs: 
Iris Hauth, Germany 
Henning Saß, Germany
001
  Was sagt die Ideengeschichte der Psychiatrie 
über deren Identität?
Paul Hoff, Switzerland
002
  Psychiatrie und Gesellschaft – Psychiatrie in  
der Gesellschaft
Arno Deister, Germany
003
  Methoden und Kompetenzen des Psychiaters
Alkomiet Hasan, Germany
004
  Psychiatrie als Beziehungsmedizin – eine  
integrative Konzeption
Thomas Fuchs, Germany
S-021 (d) 
Symposium (German)
13:30 – 15:00
 | 
Hall Helsinki 2
 
TOPIC 24:
 Forensic psychiatry and assessment
 
Begutachtung bei sexuellem Sadismus
›
 DGPPN Section: Forensische Psychiatrie
Chairs: 
Nahlah Saimeh, Germany 
Peer Briken, Germany
001
  Ein Fall von sexuell-sadistischer Graophilie
Nahlah Saimeh, Germany
002
  Wer weiß, was sexueller Sadismus ist?
Peer Briken, Germany
003
  Schwierigkeiten der Diagnostik von sexuellem 
Sadismus
Joachim Nitschke, Germany
004
  Wie gefährlich sind sexuelle Sadisten? Verlauf 
und Prognose bei Sexualstraftätern mit sexuellem 
Sadismus
Andreas Hill, Germany
S-022 (d) 
Symposium (German)
13:30 – 15:00
 | 
Hall Berlin 1
 
TOPIC 14:
 Neurobiology and genetics
 
Forschungsergebnisse aus multimodaler  
Befunderhebung bei Patienten mit Depressionen  
im naturalistischen Setting
›
 DGPPN Section: Neurobiologie und Genetik
Chairs: 
Jürgen Deckert, Germany 
Thomas G. Schulze, Germany
001
  Pharmakoepigenetik und Therapieresponse – 
Ergebnisse aus der Münster-Studie
Katharina Domschke, Germany
Peter Zwanzger, Nicola Tidow, Christiane Ziegler, Leonie 
Kollert, Jürgen Deckert, Volker Arolt, Bernhard T. Baune
002
  Die BeCOME – biological classification of  
mental disease – Studie
Martin E. Keck, Germany
003
  Therapeutisches Drug Monitoring und Pharma-
kogenetik – die Gepard und Indepth-Studien
Andreas Menke, Germany
004
  Longitudinale Forschungsansätze in der biolo-
gischen Psychiatrie: logistische Herausforderungen 
und innovatives Potential
Thomas G. Schulze, Germany
S-023 (d) 
Symposium (German)
13:30 – 15:00
 | 
Room Weimar 3
TOPIC 22:
 Community and social psychiatry
 
Neue Chancen für die Versorgung von Men-
schen mit schweren psychischen Erkrankungen 
durch PsychVVG, Pflegestärkungsgesetze und BTHG
Chairs: 
Thomas Pirsig, Germany 
Nils Greve, Germany
001
  Die Möglichkeiten aufsuchender Behandlung 
(Home Treatment) im Rahmen sogenannter  
„stationsäquivalenter Leistungen“
Nils Greve, Germany
002
  Multiprofessionalität als Erfahrung guter 
Arbeit und als Zukunftsbedingung erfolgreicher 
Versorgung
Thomas Floeth, Germany
003
  Neue Einsatzmöglichkeiten der ambulanten 
Psychiatrischen Pflege
Kay Herklotz, Germany
004
  Das neue Bundesteilhabegesetz – Chancen für 
die Versorgung
Claudia Seydholdt, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
108
SCIENTIFIC
 PROGRAMME
WS-05 Workshop
13:30 – 15:00
 | 
Room M8
TOPIC 25:
 Training and continuing education
Future approaches to education in psychiatry:  
mental health simulation training
Chairs: 
Lorena Valdearenas, United Kingdom 
Chris Attoe, United Kingdom
Speakers: 
Gregoire Billon, United Kingdom 
Catherine Wilson, United Kingdom 
Leonie Williams, United Kingdom
WS-06 Workshop
13:30 – 15:00
 | 
Room R2
TOPIC 24:
 Forensic psychiatry and assessment
Violence risk assessment: from theory to practice
Chairs: 
Britta Ostermeyer, USA 
Seena Fazel, United Kingdom
Speaker: 
Elias Abdalla-Filho, Brazil
OS-14 
Oral Presentation Session
13:30 – 15:00
 | 
Room R12
TOPIC 9:
 Comorbidity of somatic and mental disorders, 
psychosomatics
Comorbidities and psychosomatics I
Chairs: 
Isabella Heuser, Germany 
Nikolai Kornetov, Russia
001
  Impact of hearing impairment on mental 
health: an overview
Kathleen Tretbar, Germany
Marco Grabemann, Norbert Scherbaum, Sylvi Meuret, 
Jens Wiltfang, Bernhard Kis, Mona Abdel-Hamid
002
  Incidence of poststroke depression in Taiwan 
and etiology in immunity
Jian-An Su, Taiwan
003
  Adding depression and cognitive function  
to ‘frailty’ increases prediction of prognosis in  
advanced heart failure
Kay Wilhelm, Australia
Sunita Jha, Peter Macdonald, Malin Hannu, Philip 
Newton, Christopher Hayward, Andrew Jabbour, Eugene 
Kotlyar, Anne Keogh, Kumud Dhital, Emily Granger, Mark 
Connellan, Paul Jansz, Elyn Montgomery, Angela Smith, 
Peta Tunicliff, Patricia Davidson, Michelle Harkess
004
  Improving lifestyle in people with severe men-
tal illness: are we running on the right path?
Helene Speyer, Denmark
005
  Beyond a universal transsexual biography  
– diversity in treatment requests and health care 
needs among trans individuals
Andreas Köhler, Germany
Jana Eyssel, Timo Nieder
OS-15 
Oral Presentation Session
13:30 – 15:00
 | 
Room Lindau 4
TOPIC 12:
 Epidemiology and risk factors
Epidemiology and risk factors I
Chairs: 
Oye Gureje, Nigeria 
Anette Kersting, Germany
001
  Maternal sleep problems during pregnancy and 
child psychiatric problems
Marius Lahti, Finland
Theresia Mina, Amanda Drake, Anu-Katriina Pesonen, 
Katri Räikkönen, Helen Minnis, Renata Riha, Fiona 
Denison, Jane Norman, Rebecca M. Reynolds
002
  Association between age of onset of menarche 
and mental illness in women presented at tertiary 
care hospital of Karachi, Pakistan – a cross sectional 
study
Areeba Berkat, Pakistan
Majid Ali Abidi
003
  Having a functional deficit: persons at risk for 
psychosis and their trajectories of functioning
Anastasia Theodoridou, Switzerland
004
  Social isolation and loneliness predict coro-
nary heart disease and stroke incidence in the UK 
Biobank data
Christian Hakulinen, Finland
Marko Elovainio
005
  Coping with anxiety – association between cop-
ing style and limbic reactivity to threatening stimuli
Elisabeth Leehr, Germany
Ronny Redlich, Katharina Dohm, Joscha Böhnlein, Udo 
Dannlowski
OS-16 
Oral Presentation Session
13:30 – 15:00
 | 
Room Lindau 2
TOPIC 13:
 Brain imaging, neurophysiology, 
neuropsychology
Brain imaging, neurophysiology, neuropsychology I
Chairs: 
Oliver Pogarell, Germany 
Klaus Mathiak, Germany
001
  Premorbid symptoms in delirium
Mohammad Arbabi, Iran
Zhale Dezhdar, Narges Yazdi

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
109
SCIENTIFIC
 PROGRAMME
002
  Interaction between traumatic events and  
resilience affects reward processing
Anja Richter, Germany
Esther K. Diekhof, Bernd Krämer, Oliver Gruber
003
  Brain circuitries linked to opioid dependence:  
a controlled diffusion tensor imaging study
Abhishek Ghosh, India
Debasish Basu, Niranjan Khandelwal, Chirag Kamal 
Ahuja, B. N. Subodh
004
  Hippocampal volume is associated with  
psychiatric symptoms in children aged 3-5 years 
with verified maltreatment exposure
Judith Overfeld, Germany
Karin Nadig-Haynes, Karin de Punder, Peggy Dörr,  
Katja Dittrich, Gergana Karaboycheva, Sibylle Maria 
Winter, John-Dylan Haynes, Claudia Buss, Christine Heim
005
  Disrupted small-world networks in chronic 
ketamine users
Jinsong Tang, People's Republic of China
Yanhui Liao, Wei Hao
006
  Anterior Cingulate neurochemistry in OCD  
and effects of 12-week escitalopram treatment:  
a 1H-MRS study
Arpit Parmar, India
Pratap Sharan, Sudhir Khandelwal, Uma Sharma, 
Naranamangalam Jagannathan
OS-17 
Oral Presentation Session
13:30 – 15:00
 | 
Room Lindau 5
TOPIC 35:
 Psychiatry and society
Psychiatry and society
Chairs: 
Avinash DeSousa, India 
Katarina Stengler, Germany
001
  In or out? Two case studies denoting new  
conditions for partnership between psychiatrists 
and faith healers in Saudi Arabia
Asmaa Ebraheem, Egypt
002
  Assabeyya, idiom of distress: an exploration of 
Egyptian women's suffering in contemporary Cairo
Heba Allah Habib, Egypt
Abdelwahed Mekki-Berrada
003
  Dangerous or vulnerable – a genealogy of  
difficult and violent adolescents in France
Yannis Gansel, France
004
  Tandems between professionals and lay experts 
– towards sustainable mental health vs. anxiety 
disorders and depression: why – how – who?
Wolfgang Goede, Germany
Julian Kurzidim, Christian Zottl
005
  Workplace mental health and well-being – the 
role of corporate employers in improving mental 
health
Mina Carolina Hinsch, United Kingdom
Karen Taylor